Name | Povorcitinib |
---|
Description | Povorcitinib is a potent and selective inhibitor of JAK1. Povorcitinib has the potential for the research of disease selected from cutaneous lupus erythematosus (CLE) and Lichen planus (LP) (extracted from patent WO2021076124A1)[1]. |
---|---|
Related Catalog | |
Target |
JAK1[1] |
References |
Molecular Formula | C23H22F5N7O |
---|---|
Molecular Weight | 507.46 |